Frontiers in Public Health (Oct 2023)
Pan-India influenza-like illness (ILI) and Severe acute respiratory infection (SARI) surveillance: epidemiological, clinical and genomic analysis
- Varsha Potdar,
- Neetu Vijay,
- Labanya Mukhopadhyay,
- Neeraj Aggarwal,
- Sumit Dutt Bhardwaj,
- Manohar Lal Choudhary,
- Nivedita Gupta,
- Harmanmeet Kaur,
- Jitendra Narayan,
- Prabhat Kumar,
- Harpreet Singh,
- Rizwan Suliankatchi Abdulkader,
- Manoj Murhekar,
- Meena Mishra,
- Sundararajan Thangavel,
- K. Nagamani,
- Rahul Dhodapkar,
- Bashir Ahmad Fomda,
- Umesh Varshney,
- Agniva Majumdar,
- Shanta Dutta,
- P. Vijayachari,
- Jyotirmayee Turuk,
- Tapan Majumdar,
- Ganesh Chandra Sahoo,
- Krishna Pandey,
- Anudita Bhargava,
- Sanjay Singh Negi,
- Prabhat K. Khatri,
- Usha Kalawat,
- Debasis Biswas,
- Neeta Khandelwal,
- Biswajyoti Borkakoty,
- S. Manjushree,
- Mini P. Singh,
- Jyoti Iravane,
- K. Kaveri,
- G. B. Shantala,
- Megha Brijwal,
- Aashish Choudhary,
- Lalit Dar,
- Bharti Malhotra,
- Amita Jain,
- ILI-SARI Surveillance Team
Affiliations
- Varsha Potdar
- ICMR-National Institute of Virology, Pune, India
- Neetu Vijay
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Labanya Mukhopadhyay
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Neeraj Aggarwal
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Sumit Dutt Bhardwaj
- ICMR-National Institute of Virology, Pune, India
- Manohar Lal Choudhary
- ICMR-National Institute of Virology, Pune, India
- Nivedita Gupta
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Harmanmeet Kaur
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Jitendra Narayan
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
- Prabhat Kumar
- Biomedical Informatics (BMI) Division, Indian Council of Medical Research, New Delhi, India
- Harpreet Singh
- Biomedical Informatics (BMI) Division, Indian Council of Medical Research, New Delhi, India
- Rizwan Suliankatchi Abdulkader
- ICMR-National Institute of Epidemiology, Chennai, India
- Manoj Murhekar
- ICMR-National Institute of Epidemiology, Chennai, India
- Meena Mishra
- VRDL, All India Institute of Medical Sciences, Nagpur, India
- Sundararajan Thangavel
- VRDL, Government Mohan Kumaramangalam Medical College, Salem, India
- K. Nagamani
- VRDL, Gandhi Medical College, Secunderabad, India
- Rahul Dhodapkar
- VRDL, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
- Bashir Ahmad Fomda
- VRDL, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
- Umesh Varshney
- 0VRDL, Government Medical College, Haldwani, India
- Agniva Majumdar
- 1ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
- Shanta Dutta
- 1ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
- P. Vijayachari
- 2ICMR-Regional Medical Research Centre, Port Blair, India
- Jyotirmayee Turuk
- 3ICMR-Regional Medical Research Centre, Bhubaneswar, India
- Tapan Majumdar
- 4VRDL, Government Medical College, Agartala, India
- Ganesh Chandra Sahoo
- 5ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India
- Krishna Pandey
- 5ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India
- Anudita Bhargava
- 6VRDL, All India Institute of Medical Sciences, Raipur, India
- Sanjay Singh Negi
- 6VRDL, All India Institute of Medical Sciences, Raipur, India
- Prabhat K. Khatri
- 7VRDL, Dr. Sampurnanand Medical College, Jodhpur, India
- Usha Kalawat
- 8VRDL, Sri Venkateswara Institute of Medical Sciences, Tirupati, India
- Debasis Biswas
- 9VRDL, All India Institute of Medical Sciences, Bhopal, India
- Neeta Khandelwal
- 0VRDL, BJ Medical College, Ahmedabad, India
- Biswajyoti Borkakoty
- 1ICMR-Regional Medical Research Centre, Dibrugarh, India
- S. Manjushree
- 2VRDL, Government Medical College, Trivandrum, India
- Mini P. Singh
- 3VRDL, Post Graduate Institute of Medical Education and Research, Chandigarh, India
- Jyoti Iravane
- 4VRDL, Government Medical College, Aurangabad, India
- K. Kaveri
- 5VRDL, King Institute of Preventive Medicine and Research, Chennai, India
- G. B. Shantala
- 6VRDL, Bangalore Medical College and Research Institute, Bangalore, India
- Megha Brijwal
- 7VRDL, All India Institute of Medical Sciences, New Delhi, India
- Aashish Choudhary
- 7VRDL, All India Institute of Medical Sciences, New Delhi, India
- Lalit Dar
- 7VRDL, All India Institute of Medical Sciences, New Delhi, India
- Bharti Malhotra
- 8VRDL, Sawai Man Singh Medical College, Jaipur, India
- Amita Jain
- 9VRDL, King George’s Medical University, Lucknow, India
- ILI-SARI Surveillance Team
- DOI
- https://doi.org/10.3389/fpubh.2023.1218292
- Journal volume & issue
-
Vol. 11
Abstract
BackgroundOver time, COVID-19 testing has significantly declined across the world. However, it is critical to monitor the virus through surveillance. In late 2020, WHO released interim guidance advising the use of the existing Global Influenza Surveillance and Response System (GISRS) for the integrated surveillance of influenza and SARS-CoV-2.MethodsIn July 2021, we initiated a pan-India integrated surveillance for influenza and SARS-CoV-2 through the geographically representative network of Virus Research and Diagnostic Laboratories (VRDLs) across 26 hospital and laboratory sites and 70 community sites. A total of 34,260 cases of influenza-like illness (ILI) and Severe acute respiratory infection (SARI) were enrolled from 4 July 2021 to 31 October 2022.FindingsInfluenza A(H3) and B/Victoria dominated during 2021 monsoon season while A(H1N1)pdm09 dominated during 2022 monsoon season. The SARS-CoV-2 “variants of concern” (VoC) Delta and Omicron predominated in 2021 and 2022, respectively. Increased proportion of SARI was seen in extremes of age: 90% cases in < 1 year; 68% in 1 to 5 years and 61% in ≥ 8 years age group. Approximately 40.7% of enrolled cases only partially fulfilled WHO ILI and SARI case definitions. Influenza- and SARS-CoV-2-infected comorbid patients had higher risks of hospitalization, ICU admission, and oxygen requirement.InterpretationThe results depicted the varying strains and transmission dynamics of influenza and SARS-CoV-2 viruses over time, thus emphasizing the need to continue and expand surveillance across countries for improved decision making. The study also describes important information related to clinical outcomes of ILI and SARI patients and highlights the need to review existing WHO ILI and SARI case definitions.
Keywords